Novartis Stock Shows Rising Relative Strength; Mostly V-Shape Recovery From Covid CrashInvestors Business Daily • 05/12/20
Novartis AG (NVS) CEO Vasant Narasimhan on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 04/28/20
FDA Tells Healthcare Providers: Stop Treating COVID-19 Outpatients with Malaria DrugsThe Motley Fool • 04/24/20
Hydroxychloroquine Flops as a COVID-19 Treatment, Retrospective Analysis FindsThe Motley Fool • 04/22/20
Novartis to conduct hydroxychloroquine trial for hospitalized COVID-19 patientsMarket Watch • 04/20/20